Karyopharm Therapeutics Stock Falls 13% After Announcing $100 Mln Financing Deal

(RTTNews) - Karyopharm Therapeutics Inc. (KPTI) dropped 11.86 percent, declining $0.68 to $5.09 on Wednesday, after the company announced a series of financing and capital structure transactions expected to provide $100 million in funding and extend its cash runway into the second quarter of 2026.

The stock is currently trading at $5.03, compared with a previous close of $5.77 on the Nasdaq. Shares opened at $4.65 and have traded between $4.51 and $5.15 so far today, with trading volume rising to 2.1 million shares, well above the average of 173,000.

Over the past 52 weeks, Karyopharm shares have ranged between $3.51 and $16.95.